Identification and Synthesis of Buctopamine,a Novel β2 Receptor Agonist

来源 :第九届IUPAC化学生物学国际研讨会暨第八届世界华人药物化学研讨会 | 被引量 : 0次 | 上传用户:HIT_Happy
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Ractopamine,a potent β2 receptor agonist,is widely used in agriculture for growth promotion of livestock.However,it is forbidden as feed additive in Europe,China and Taiwan,and other β2 receptor agonists are used as alternatives.Recently,buctopamine,a novel β2 receptor agonist,was found to be used in Taiwan.Here,we report the identification of buctopamine and one of its metabolite,mebuctopamine,and the synthesis of buctopamine and mebuctopamine as reference standards for qualitative and quantitative analysis of illegal use of related β2 receptor agonists in animals.
其他文献
A series of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides were synthesized and investigated for their antiangiogenic activity by application of tube formation assay using HUVECs1,the rat thoracic aort
会议
Glutathione S-transferases π (GSTπ) catalyzes the conjugation of glutathione (GSH) to an electrophilic center of endogenous and exogenous compounds and is frequently over-expressed in many human tumor
会议
The EGFR T790M mutant contributes approximately 50% to clinically acquired resistance against gefitinib or erlotinib.Irreversible EGFR inhibitors can overcome the EGFR T790M-related resistance.1,2 The
会议
Based on the novel anti-CRF activity of the lead compound skimmin,which was isolated from Hydragangea Macrophylla,a series of coumarin derivatives were designed and synthesized and their biological ac
会议
Poly (ADP-ribose) polymerase-1(PARP-1) is a nuclear enzyme involved in the detection and repair of DNA damage.Early studies identified nicotinamide(1a) as the PARP-1 inhibitor[1].Recently,the studies
会议
In continuation of our efforts toward the discovery of potent HIV-1 NNRTIs with novel structures [1,2],we have employed a scaffold hopping strategy [3] to explore the chemically diverse space of bioac
会议
The development of novel anti-thrombotic agents with strong free radical scavenging activity is of great significance for the treatment of ischemic stroke.1 In the present study,3-alkyl/arylalkyl-subs
会议
Inhibition of the vascular endothelial growth factor receptor(VEGFR) has emerged as one of the most promising new method for cancer therapy.Based on the computer technology,one compound with the pyraz
会议
STAT3 is a promising anticancer drug target.Its activation involves dimerization via intermolecular pTyr-SH2 interaction[1].Thus,blocking this interaction is a feasible approach to inhibit STAT3 activ
会议
Oleanolic acid is a triterpenoid saponin which possesses multiple biological activities such as anti-osteoporosis,anti-inflammation,liver protection and anti-tumor.Regarding its anti-tumor activity,3-
会议